FK 565
Alternative Names: FR 41565Latest Information Update: 31 Mar 1995
At a glance
- Originator Fujisawa
- Class Antineoplastics; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Viral infections
Most Recent Events
- 31 Mar 1995 Discontinued-I for Cancer in USA (Unknown route)
- 31 Mar 1995 Discontinued-II for Viral infections in USA (Parenteral)
- 31 Mar 1995 Discontinued-Preclinical for Viral infections in Japan (Parenteral)